Florian Bassermann

The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm et al. · Science · 2017 · 845 citations · Full text

Tumor Biology, Proteomicsdb Database, Drug Target +14

SCF ^Fbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins

Luca Busino, Florian Bassermann, Alessio Maiolica et al. · Science · 2007 · 494 citations

Molecular Regulation, Molecular Biology, Cryptochrome +17

The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint

Florian Bassermann, David Frescas, Daniele Guardavaccaro et al. · Cell · 2008 · 398 citations · Full text

Genome Instability, Cdc14b-cdh1-plk1 Axis Controls, Cell Division +5

JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes

David Frescas, Daniele Guardavaccaro, Florian Bassermann et al. · Nature · 2007 · 279 citations

Chromatin, Transcriptional Regulation, Natural Sciences +9

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen et al. · Annals of Oncology · 2019 · 232 citations · Full text